$2.24
-0.08 (-3.45%)
Open$2.30
Previous Close$2.32
Day High$2.32
Day Low$2.18
52W High$5.59
52W Low$2.37
Volume—
Avg Volume64.6K
Market Cap279.52M
P/E Ratio—
EPS$-0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,632.6% upside
Current
$2.24
$2.24
Target
$38.81
$38.81
$30.55
$38.81 avg
$50.01
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 870.83M | 734.82M | 117.29M |
| Net Income | -74,396,825 | -56,499,149 | 15.94M |
| Profit Margin | -8.5% | -8.1% | 13.6% |
| EBITDA | 15.20M | 12.19M | 20.19M |
| Free Cash Flow | — | — | 10.06M |
| Rev Growth | +18.5% | +18.5% | +17.8% |
| Debt/Equity | 1.25 | 1.25 | 1.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |